MarketCapExport financials
Hims & Hers Health (HIMS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Hims & Hers Health Cash Flow 2025-2011 | HIMS
Brief overview of Hims & Hers Health's cash flow quality
The comparison covers five available annual reports between 2021 and 2025.
Core operations moved from negative cash flow of -$34.4 million to an inflow of $300 million, an important positive shift.
Operations produced positive cash in 3 of five years. Weak periods reduce predictability.
Operating cash flow margin improved from -12.7% to 12.8%. The quality of revenue growth strengthened.
Cash flow takeaway
Hims & Hers Health's cash flow sends more positive than negative signals, but receipt quality should be confirmed in future reports.
Annual Cash Flow Hims & Hers Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
300 M | 251 M | 73.5 M | -26.5 M | -34.4 M | -2.48 M | -74.9 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
54.5 M | 17.1 M | 9.52 M | 7.47 M | 4.08 M | 1.06 M | 260 K | - | - | - | - | - | - | - | - |
Accounts Payables |
143 M | 91.2 M | 43.1 M | 32.4 M | 19.6 M | 8.07 M | 7.23 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
32.1 M | 6.1 M | 6.7 M | 3.9 M | 4.1 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
80.1 M | 64.4 M | 22.5 M | 21.6 M | 13.6 M | 3.54 M | 4.22 M | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Cash Flow Hims & Hers Health
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -35.9 M | 89.4 M | 61.3 M | 149 M | -19.1 M | 109 M | 86.4 M | 85.3 M | 53.6 M | 25.8 M | 22 M | 25.2 M | 16.8 M | 9.48 M | -6.72 M | 5.98 M | -6.39 M | -19.4 M | -3.1 M | -16 M | 601 K | -15.9 M | -269 K | 3.14 M | -155 K | -5.19 M | -74.7 M | -207 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
27.3 M | 18.7 M | 12.5 M | 9.6 M | 9.2 M | 2.8 M | 2.1 M | 1.4 M | 900 K | 800 K | 700 K | 700 K | 800 K | 1 M | 1 M | 1 M | 1 M | 1.1 M | 1 M | 1 M | 1 M | 100 K | 100 K | -592 K | 300 K | 212 K | 180 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
516 M | 501 M | 307 M | 143 M | 198 M | 105 M | 109 M | 91.2 M | 75.4 M | 57.1 M | 43.9 M | 43.1 M | 42 M | 38.3 M | 37.6 M | 32.4 M | 33 M | 27.1 M | 23.9 M | 19.6 M | 16.1 M | 15.6 M | 13.2 M | 8.07 M | 24.7 K | 21.7 K | 74.6 K | 18.5 K | 476 K | 22 K | 18.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
428 M | 375 M | 150 M | 32.1 M | - | - | - | 6.1 M | - | - | - | 6.7 M | - | - | - | 3.9 M | - | - | - | 4.1 M | - | - | - | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
108 M | 87.8 M | 79.1 M | 80.1 M | 106 M | 142 M | 76.1 M | 64.4 M | 49.1 M | 40.6 M | 29.8 M | 22.5 M | 22 M | 21.4 M | 20.7 M | 21.6 M | 22.3 M | 19.7 M | 12.1 M | 13.6 M | 10.9 M | 6.59 M | 4.52 M | 3.54 M | 3.54 M | 3.54 M | 3.54 M | 4.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Hims & Hers Health, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Household products sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B |  USA |
 |
The Estée Lauder Companies
EL
|
$ 113.35 | 0.17 % | $ 41.1 B | USA |
 |
Unilever PLC
UL
|
$ 66.48 | -0.2 % | $ 145 B |  Britain |
 |
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | USA |
 |
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | USA |
 |
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | USA |
 |
Coty
COTY
|
$ 4.34 | 2.73 % | $ 3.81 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M |  China |
 |
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M |  Bermuda |
 |
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | USA |
 |
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.62 | -3.69 % | $ 16.4 M | USA |
 |
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.04 | -5.61 % | $ 199 M | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B | USA |